Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lowri Cochlin

Lowri’s work focuses on the clinical translation of hyperpolarised MRI, with emphasis on training, standardisation and multi‑centre collaboration. She is developing a formally endorsed training programme for graduate students, clinicians, researchers and MRI practitioners, and supports a multi‑centre hyperpolarised brain MRI study to assess reproducibility and establish baseline pyruvate metabolism. She also contributes to hyperpolarised xenon MRI projects investigating lung structure and gas‑exchange.

Her research aims to standardise and validate hyperpolarised MRI for metabolic and physiological applications. She uses dissolution DNP for metabolic imaging and will soon begin work with a Polarean xenon hyperpolariser. Current projects span training, reproducibility evaluation and the creation of healthy reference datasets to support future clinical translation.

Lowri’s technical expertise includes MRI, dissolution DNP and RF coil design. She is part of OCMR within the Radcliffe Department of Medicine and the University of Oxford Medical Sciences Division. She studied Chemistry at the University of York, completed a Master’s in Industry at DSM in Maastricht, earned her DPhil in Medical Physics at Oxford, and has worked in both academic and commercial MRI roles, returning to academia in 2023 and joining OCMR in 2025.